**Core Concept**
Malaria chemoprophylaxis is essential for travelers visiting endemic areas. Chloroquine resistance in Plasmodium falciparum necessitates the use of alternative drugs for effective prevention.

**Why the Correct Answer is Right**
Atovaquone-proguanil (Malarone) is a preferred chemoprophylactic agent for low-level chloroquine-resistant falciparum malaria due to its high efficacy and relatively low side effect profile. Atovaquone inhibits mitochondrial electron transport in the parasite, while proguanil acts as a competitive inhibitor of dihydrofolate reductase. This combination prevents the development of resistance and is effective against both chloroquine-sensitive and -resistant strains.

**Why Each Wrong Option is Incorrect**
**Option A:** Chloroquine is not recommended for chemoprophylaxis in areas with low-level chloroquine-resistant falciparum malaria due to its reduced efficacy.
**Option B:** Doxycycline is an alternative chemoprophylactic agent but is associated with a higher risk of side effects and is generally reserved for areas with high resistance to atovaquone-proguanil.
**Option C:** Mefloquine is another option but has a higher risk of neurological side effects, particularly in women and individuals with a history of psychiatric disorders.

**Clinical Pearl / High-Yield Fact**
Travelers to malaria endemic areas should consult their healthcare provider at least 4-6 weeks prior to travel to determine the most effective chemoprophylaxis regimen based on the destination's malaria risk and resistance patterns.

**Correct Answer:** C.